IDWeek 2017

Antibiotic Stepdown Tx for Uncomplicated Gram-Negative Bloodstream Infections

Antibiotic Stepdown Tx for Uncomplicated Gram-Negative Bloodstream Infections

By

For uncomplicated Gram-negative bloodstream infections, oral beta-lactam therapy may be an appropriate stepdown option.

Inappropriate Antibiotic Prescribing Rates High for Uncomplicated UTIs

Inappropriate Antibiotic Prescribing Rates High for Uncomplicated UTIs

By

Inappropriate prescribing of outpatient antibiotics for the treatment of uncomplicated urinary tract infections are higher than previously estimated.

Isoniazid-Rifapentine for Latent TB Sees High Completion Rates

Isoniazid-Rifapentine for Latent TB Sees High Completion Rates

By

Isoniazid-rifapentine regimen sees high completion rates for latent tuberculosis infection.

Efficacy of Continuous vs Intermittent Vancomycin for Pediatric MRSA Infections Evaluated

Efficacy of Continuous vs Intermittent Vancomycin for Pediatric MRSA Infections Evaluated

By

Vancomycin administered via continuous infusion was found to achieve the recommended VAN trough of 15-20mg/L faster and with less risk of adverse events compared to administration via intermittent infusion.

Incidence of STI in PrEP Users Who Report Alcohol/Drug Use

Incidence of STI in PrEP Users Who Report Alcohol/Drug Use

By

The aim of this study was to identify and characterize PrEP patients who remain at high risk for HIV as demonstrated by STI diagnosis after starting PrEP.

Infant Gut Microbiome Altered by Maternal Antibiotic Use

Infant Gut Microbiome Altered by Maternal Antibiotic Use

By

Mothers' use of antibiotics affects infant gut composition up to a month later.

Safety, Efficacy of TAF vs TDF in HIV+ Adults Stratified by Race

Safety, Efficacy of TAF vs TDF in HIV+ Adults Stratified by Race

By

Among HIV-infected, virologically suppressed black adults, FTC/TAF showed improvements in renal and bone safety compared to FTC/TDF.

HIV/HCV Co-Infections: Barriers to Effective Treatment

HIV/HCV Co-Infections: Barriers to Effective Treatment

By

Only a small percentage of people with HIV/HCV co-infection receive treatment for hepatitis C.

Frequent Syphilis Screening Necessary for High-Risk Populations

Frequent Syphilis Screening Necessary for High-Risk Populations

By

In 2004, syphilis screening guidelines were changed to recommend rapid plasma regain testing every 3 to 6 months.

Latent Tuberculosis May Benefit From 3-Month Rifapentine, Isoniazid Tx

Latent Tuberculosis May Benefit From 3-Month Rifapentine, Isoniazid Tx

By

Three months of rifapentine + isoniazid using directly observed therapy resulted in a higher completion rate and no loss of follow-up for latent tuberculosis.

Challenges in Multidrug-Resistant HIV Management: Ibalizumab Safe, Effective

Challenges in Multidrug-Resistant HIV Management: Ibalizumab Safe, Effective

By

Ibalizumab may be a valuable option in patients with multidrug-resistant HIV.

Examining Drug-Drug Interactions in Women With HIV: ART and Hormonal Contraception

Examining Drug-Drug Interactions in Women With HIV: ART and Hormonal Contraception

By

Examining the barriers to co-use of hormonal contraceptives and antiretroviral therapy in women with HIV.

Abacavir ART Does Not Increase Risk for Myocardial Infarction or CVD

Abacavir ART Does Not Increase Risk for Myocardial Infarction or CVD

By

Abacavir-containing antiretroviral therapy does not appear to confer an increased risk for myocardial infarction or coronary artery disease.

The T2Candida Panel Has Decreased Time to Therapy Initiation for Candidemia

The T2Candida Panel Has Decreased Time to Therapy Initiation for Candidemia

By

Antimicrobial stewardship traditionally focuses on optimal use of antibacterial agents, not antifungal therapy.

Efficacy of Procalcitonin-Guided Antimicrobial Stewardship Initiative for Diagnosing Pneumonia

Efficacy of Procalcitonin-Guided Antimicrobial Stewardship Initiative for Diagnosing Pneumonia

By

Implementation of a procalcitonin diagnostic algorithm improves diagnostic yield and reduces hospital length of stay in bacterial pneumonia.

Ribaxamase May Prevent Opportunistic Infections During IV β-lactam Treatment

Ribaxamase May Prevent Opportunistic Infections During IV β-lactam Treatment

By

SYN-004, ribaxamase, is an oral B-lactamase medication to be combined with intravenous β-lactam antibiotics to prevent disruption of the gut microbiome.

Minorities With Low Income and Poor Education Receive Lower Uptake of PCV13

Minorities With Low Income and Poor Education Receive Lower Uptake of PCV13

By

Multiple disparities exist in rates of adult vaccination for 13-valent pneumococcal conjugate vaccine.

Accuracy of Negative Tuberculin Skin Test in Predicting In-Hospital Tuberculosis  Mortality

Accuracy of Negative Tuberculin Skin Test in Predicting In-Hospital Tuberculosis Mortality

By

The relationship between negative tuberculin skin test and in-hospital mortality has not been previously studied.

Stroke Outcomes Similar in People With, Without HIV

Stroke Outcomes Similar in People With, Without HIV

By

Stroke outcomes between people with and without HIV were comparable.

Efficacy of Delafloxacin in Treating Community-Acquired Bacterial Pneumonia

Efficacy of Delafloxacin in Treating Community-Acquired Bacterial Pneumonia

By

The efficacy of delafloxacin in treating Streptococcus pneumoniae, Haemophilius influenzae, and Moraxella catarrhalis isolates was examined.

Dyslipidemia in Children With HIV Started on Antiretroviral Therapy

Dyslipidemia in Children With HIV Started on Antiretroviral Therapy

By

Researchers aim to identify changes in blood lipid profiles among children with HIV after 12 months of using antiretroviral therapy.

Recurrent Acute Uncomplicated Cystitis in Women: Examining the Efficacy of Preventive Hydration

Recurrent Acute Uncomplicated Cystitis in Women: Examining the Efficacy of Preventive Hydration

By

Data to support hydration as a preventive measure for women with recurrent acute uncomplicated cystitis are sparse.

EMERALD Trial: Week 48 Results Demonstrate Efficacy in Single-Tablet HIV Therapy

EMERALD Trial: Week 48 Results Demonstrate Efficacy in Single-Tablet HIV Therapy

By

Primary study end point was noninferiority of the single-tablet regimen vs control, related to virologic rebound, cumulative through week 48.

T2 Candida Panel is Superior to Blood Cultures for Identifying Candidemia

T2 Candida Panel is Superior to Blood Cultures for Identifying Candidemia

By

Compared to blood cultures, T2 Candida Panel is faster and more sensitive in detecting Candidemia.

Macrolides Superior to Beta-Lactams in Pediatric Community-Acquired Pneumonia

Macrolides Superior to Beta-Lactams in Pediatric Community-Acquired Pneumonia

By

Macrolides, despite inferior anti-pneumococcal activity, are the most commonly prescribed antibiotic class for CAP in Children.

Delafloxacin: Tolerable, Effective Against Gram-Negative Pathogens for ABSSSI

Delafloxacin: Tolerable, Effective Against Gram-Negative Pathogens for ABSSSI

By

Delafloxacin is effective against gram-negative pathogens and has a similar tolerability profile to vancomycin/aztreonam when used in patients with an ASSSSI.

"Hard Stop" Alert May Reduce <i>C difficile</i> Orders for Laxative-Taking Patients

"Hard Stop" Alert May Reduce C difficile Orders for Laxative-Taking Patients

By

A "hard stop" requiring providers to think critically about C difficile testing in the presence of laxative use or absence of documented diarrhea strengthened CDI testing stewardship.

Delafloxacin is Effective, Safe for MRSA Treatment in ABSSSI

Delafloxacin is Effective, Safe for MRSA Treatment in ABSSSI

By

Fixed dose delafloxacin IV/oral monotherapy was comparable to vancomycin/aztreonam in patients with ABSSSI and gram-positive pathogens.

Do Traditional Risk Factors for CVD Play Larger Role in HIV-Positive Premenopausal Women?

Do Traditional Risk Factors for CVD Play Larger Role in HIV-Positive Premenopausal Women?

By

Traditional risk factors may incur a higher risk for CVD in HIV-positive premenopausal women than HIV infection itself.

Safety, Immunogenicity of Investigational Zika Vaccine Examined

Safety, Immunogenicity of Investigational Zika Vaccine Examined

By

Volunteer participants received either 1 mg or 2 mg doses of the GLS-5700 vaccine over 12 weeks.

Sign Up for Free e-newsletters